Angina

Clinical Trial Finder

Many patients with angina are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

The SHINE-CTO Trial

Conditions:   Coronary Artery Disease;   Chronic Total Occlusion of Coronary Artery;   Percutaneous Transluminal Coronary Angioplasty
Interventions:   Procedure: Chronic Total Occlusion Percutaneous Coronary Intervention;   Procedure: Sham Procedure
Sponsor:   North Texas Veterans Healthcare System
Enrolling by invitation - verified May 2016

CT Perfusion Added to CT Angiography

Condition:   Angina Pectoris
Intervention:   Procedure: Cardiac computed tomography
Sponsor:   Universitaire Ziekenhuizen Leuven
Not yet recruiting - verified May 2016

Intracoronary Thrombus Detection by Magnetic Resonance Imaging

Conditions:   Angina Pectoris;   Angina, Stable;   Angina, Unstable;   Myocardial Infarction
Interventions:   Other: Magnetic Resonance Imaging;   Device: Optical Coherence Tomography;   Procedure: Invasive Coronary Angiography
Sponsor:   University of Edinburgh
Not yet recruiting - verified March 2016

Self-apposing Stentys Stents Registry

Condition:   Coronary Artery Disease
Intervention:  
Sponsor:   Azienda Ospedaliera Città della Salute e della Scienza di Torino
Not yet recruiting - verified May 2016

Mindfulness & Stress Management Study for Cardiac Patients

Conditions:   Heart Diseases;   Heart Failure;   Myocardial Infarction;   Chronic Stable Angina;   Coronary Artery Bypass;   Angioplasty
Intervention:   Behavioral: Mindfulness-Based Stress Reduction (MBSR).
Sponsors:   University of Minnesota - Clinical and Translational Science Institute;   Fairview Health Services
Recruiting - verified May 2016

Ivabradine and Post-revascularisation Microcirculatory Dysfunction

Conditions:   Coronary Artery Disease;   Angina
Intervention:   Drug: Ivabradine
Sponsor:   Liverpool Heart and Chest Hospital NHS Foundation Trust
Suspended - verified May 2016

Comparison of Anticoagulation for All-comers Undergoing Percutaneous Coronary Revascularization Trial

Condition:   Percutaneous Coronary Intervention
Interventions:   Drug: Bivalirudin;   Drug: Unfractionated heparin
Sponsor:   Kaiser Permanente
Terminated - verified May 2015

A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.

Condition:   Essential Hypertension With Stable Angina and Dyslipidemia
Intervention:   Drug: Azilsartan
Sponsor:   Takeda
Withdrawn - verified May 2016

Diagnostic Imaging Strategies for Patients With Stable Chest Pain and Intermediate Risk of Coronary Artery Disease

Condition:   Coronary Artery Disease
Interventions:   Procedure: Computed tomography angiography (cardiac CT);   Procedure: Invasive coronary angiography (ICA)
Sponsor:   Charite University, Berlin, Germany
Recruiting - verified May 2016

Antiplatelet Therapy Following Stent Implantation

Conditions:   Acute Myocardial Infarction;   Coronary Syndrome;   Angina, Unstable
Intervention:  
Sponsor:   Elpen Pharmaceutical Co. Inc.
Completed - verified May 2016

Microvascular Disease Exercise Trial

Condition:   Coronary Microvascular Disease
Interventions:   Behavioral: Exercise Program;   Drug: Medical Therapy
Sponsors:   University of Virginia;   Astellas Pharma Global Development, Inc.;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified May 2016

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Condition:   Cardiovascular Disease
Interventions:   Drug: bococizumab (PF-04950615);   Drug: Placebo
Sponsor:   Pfizer
Recruiting - verified May 2016

Effects of Ranolazine and Exercise on Daily Physical Activity Trial

Condition:   Chronic Stable Angina
Interventions:   Drug: Ranolazine;   Behavioral: Aerobic Exercise;   Drug: Placebo
Sponsors:   Duke University;   Gilead Sciences
Recruiting - verified May 2016

Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Placebo;   Drug: Linagliptin
Sponsors:   Boehringer Ingelheim;   Eli Lilly and Company
Recruiting - verified May 2016

A Study to Assess Cardiovascular Outcomes Following Treatment With Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (MK-3102-018)

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Omarigliptin;   Drug: Placebo
Sponsor:   Merck Sharp & Dohme Corp.
Terminated - verified May 2016

Acute Versus Subacute Angioplasty in Patients With NON-ST-Elevation Myocardial Infarction

Condition:   Myocardial Infarction
Intervention:   Procedure: Group I: Primary PCI
Sponsor:   Aarhus University Hospital Skejby
Terminated - verified May 2016

A Post Marketing Surveillance to Evaluate the Safety and Efficacy of Brilinta

Condition:   Acute Coronary Syndromes
Intervention:  
Sponsor:   AstraZeneca
Active, not recruiting - verified May 2016

International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)

Conditions:   Cardiovascular Diseases;   Coronary Disease;   Coronary Artery Disease;   Heart Diseases;   Myocardial Ischemia
Interventions:   Procedure: cardiac catheterization;   Procedure: coronary artery bypass graft surgery;   Procedure: percutaneous coronary intervention;   Behavioral: Lifestyle;   Drug: Medication
Sponsors:   New York University School of Medicine;   New York University;   Stanford University;   National Heart, Lung, and Blood Institute (NHLBI);   Albany Stratton VA Medical Center;   Cedars-Sinai Medical Center;   Columbia University;   Duke University;   East Carolina University;   Emory University;   Harvard University;   Massachusetts General Hospital;   Montreal Heart Institute;   University of British Columbia;   University of Missouri, Kansas City;   Vanderbilt University
Recruiting - verified May 2016

A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease

Condition:   Crohn's Disease
Interventions:   Drug: CP-690,550;   Drug: CP-690,550
Sponsor:   Pfizer
Recruiting - verified May 2016

International Survey of Acute Coronary Syndromes in Transitional Countries

Conditions:   Acute Coronary Syndrome;   Unstable Angina Pectoris;   Myocardial Infarction;   Coronary Disease
Intervention:  
Sponsor:   University of Bologna
Recruiting - verified May 2016

Trial of Drug Eluting Stent Versus Bare Metal Stent to Treat Coronary Artery Stenosis

Conditions:   Coronary Atherosclerosis;   Angina Pectoris;   Myocardial Infarction
Interventions:   Device: Percutaneous coronary intervention (PCI);   Device: Percutaneous coronary intervention (PCI)
Sponsors:   University of Tromso;   The Research Council of Norway;   The Royal Norwegian Ministry of Health;   Norwegian Council on Cardiovascular diseases
Active, not recruiting - verified May 2016